-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Aerie Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2021.
- Aerie Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 47.8M shares, a 3.19% increase year-over-year.
- Aerie Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 46.3M shares, a 0.96% increase from 2020.
- Aerie Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 45.9M shares, a 1.04% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)